Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jiangsu Changqing Agrochemical Co., Ltd. (002391.SZ)
Yangzhou, CN
Jiangsu Changqing Agrochemical Co., Ltd. operates as a manufacturer and distributor of agrochemical products, serving markets in China, Europe, the United States, and Southeast Asia. The company's product portfolio is comprehensive, featuring a wide array of technical-grade active ingredients such as fomesafen, acifluorfen, fluoroglycofen-ethyl, lactofen, clomazone, imazethapyr, bromoxynil octanoate, nicosulfuron, benazolin-ethyl, clethodim, tricyclazole, fenoxanil, imidacloprid, acetamiprid, diafenthiuron, mesotrione, s-metolachlor, clodinafop-propargyl, dicamba, indoxacarb, fipronil, thiamethoxam, indoxacarb technical concentrate, clethodim mother liquor, cyhalofop-butyl active compound, prosulfuron active compound, pretilachlor active compound, azoxystrobin active compound, glyphosate active compound, chlorpyrifos active compound, triazophos, dimethazone, and triasulfuron active compound materials. Additionally, it provides finished formulations, which encompass insecticides, bactericides, and herbicides. The company's headquarters are located in Yangzhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.18% | -5.88% | -15.15% | -16.42% | -7.89% | -5.56% | -1.23% | -22.44% | -20.23% | -38.53% | -64.58% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+4.6% Q1'26: +8.3% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+134.1% ★ Q1'26: +84.3% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+3.2% Q1'26: -33.3% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+3.1% Q1'26: +5.4% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+1.9% Q1'26: +3.2% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%-1.9% ★ Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×4.61× Q1'26: 14.79× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.82B
est: 2.05B (-11.1%)
|
1.83B
est: 1.89B (-3.0%)
|
2.25B
est: 2.13B (+5.7%)
|
3.00B
est: 3.00B (-0.1%)
|
3.38B
est: 3.40B (-0.7%)
|
3.01B
est: 3.73B (-19.2%)
|
3.76B
est: 3.93B (-4.1%)
|
4.59B
est.
|
4.24B
est: 4.35B (-2.3%)
|
3.61B
est: 4.35B (-16.8%)
|
3.52B
est: 4.29B (-17.9%)
|
3.69B
est: 3.90B (-5.6%)
|
3.95B
3.95B – 3.95B
+1.3% YoY
|
4.22B
4.22B – 4.22B
+6.7% YoY
|
| EBITDA |
396.93M
est: 267.23M (+48.5%)
|
338.08M
est: 246.50M (+37.2%)
|
473.34M
est: 277.14M (+70.8%)
|
584.44M
est: 391.79M (+49.2%)
|
667.12M
est: 443.53M (+50.4%)
|
452.82M
est: 485.82M (-6.8%)
|
560.40M
est: 512.03M (+9.4%)
|
599.02M
est.
|
642.06M
est: 566.68M (+13.3%)
|
481.11M
est: 566.68M (-15.1%)
|
247.12M
est: 552.17M (-55.2%)
|
516.53M
est: 502.34M (+2.8%)
|
508.77M
508.77M – 508.77M
+1.3% YoY
|
542.62M
542.62M – 542.62M
+6.7% YoY
|
| EBIT |
280.92M
est: 100.94M (+178.3%)
|
206.51M
est: 93.11M (+121.8%)
|
293.78M
est: 104.68M (+180.6%)
|
384.04M
est: 147.99M (+159.5%)
|
457.97M
est: 167.53M (+173.4%)
|
225.91M
est: 183.50M (+23.1%)
|
306.92M
est: 193.41M (+58.7%)
|
226.26M
est.
|
333.07M
est: 214.05M (+55.6%)
|
125.46M
est: 214.05M (-41.4%)
|
-77.75M
est: 174.32M (-144.6%)
|
112.42M
est: 158.59M (-29.1%)
|
160.62M
160.62M – 160.62M
+1.3% YoY
|
171.31M
171.31M – 171.31M
+6.7% YoY
|
| Net Income |
237.56M
est: 322.86M (-26.4%)
|
162.65M
est: 228.34M (-28.8%)
|
227.90M
est: 290.29M (-21.5%)
|
319.43M
est: 378.08M (-15.5%)
|
370.84M
est: 439.69M (-15.7%)
|
194.96M
est: 407.82M (-52.2%)
|
248.53M
est: 324.98M (-23.5%)
|
375.96M
est.
|
262.35M
est: 267.63M (-2.0%)
|
73.11M
est: 267.63M (-72.7%)
|
-119.95M
est: 50.05M (-339.7%)
|
40.54M
est: 68.82M (-41.1%)
|
125.12M
125.12M – 125.12M
+81.8% YoY
|
181.42M
181.42M – 181.42M
+45.0% YoY
|
| SGA |
194.78M
est: 41.16M (+373.2%)
|
232.70M
est: 37.97M (+512.9%)
|
193.97M
est: 42.69M (+354.4%)
|
220.06M
est: 60.34M (+264.7%)
|
235.78M
est: 68.31M (+245.1%)
|
193.06M
est: 74.83M (+158.0%)
|
209.28M
est: 78.86M (+165.4%)
|
92.26M
est.
|
216.32M
est: 87.28M (+147.8%)
|
189.09M
est: 87.28M (+116.6%)
|
191.26M
est: 197.15M (-3.0%)
|
61.27M
est: 179.36M (-65.8%)
|
181.66M
181.66M – 181.66M
+1.3% YoY
|
193.74M
193.74M – 193.74M
+6.7% YoY
|
| EPS |
0.46
est: 0.51 (-9.2%)
|
0.30
est: 0.36 (-16.3%)
|
0.42
est: 0.46 (-7.8%)
|
0.59
est: 0.59 (-0.6%)
|
0.69
est: 0.69 (+0.0%)
|
0.31
est: 0.64 (-51.6%)
|
0.38
est: 0.51 (-25.5%)
|
0.59
est.
|
0.40
est: 0.42 (-4.8%)
|
0.11
est: 0.42 (-73.8%)
|
-0.19
est: 0.08 (-337.5%)
|
0.06
est: 0.11 (-41.1%)
|
0.20
0.20 – 0.20
+81.8% YoY
|
0.29
0.29 – 0.29
+45.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 9.0K | 0.26% |
| 2 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 4.0K | 0.48% |
| 3 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 443.2K | 0.06% |
| 4 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 712.18 | 0.22% |
| 5 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 2.1K | 0.22% |
| 6 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.2K | 0.22% |
| 7 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 507.92 | 0.22% |
| 8 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 58.69 | 0.22% |
| 9 | Vanguard Retirement Income ETF Portfolio VRIF.TO | 0.00% | 19.28 | 0.31% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 9.17 | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Changqing Ma | Deputy GM, Chief Financial Officer & Secretary | — | male |
| Cheng Li | Deputy General Manager | — | male |
| Gang Du | Deputy GM & Non-Independent Director | — | male |
| He Zhao | Deputy General Manager | — | male |
| Hui Wang | Deputy General Manager | — | male |
| Jian Li | Deputy General Manager | — | male |
| Liang Zhong Lu | Chief Engineer | — | male |
| Qingzhu Kong | Deputy General Manager | — | male |
| Xialin Sun | GM & Non-Independent Director | — | male |
| Yu Guoquan | Chairman of the Board | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002391.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
